1,595
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson’s disease

, , , , , , , ORCID Icon, ORCID Icon & show all
Pages 3143-3153 | Published online: 11 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yanling Shen, Huiling Lu, Runnan Xu, Haibo Tian, Xuewei Xia, Fiona H Zhou, Liping Wang, Jianghui Dong & Liyuan Sun. (2020) The Expression of GLAST and GLT1 in a Transient Cerebral Ischemia Mongolian Gerbil Model. Neuropsychiatric Disease and Treatment 16, pages 789-800.
Read now

Articles from other publishers (14)

Aparna Ann Mathew & Rajitha Panonnummal. (2022) A Mini Review on the Various Facets Effecting Brain Delivery of Magnesium and Its Role in Neurological Disorders. Biological Trace Element Research 201:9, pages 4238-4253.
Crossref
Ikuko Miyazaki & Masato Asanuma. (2023) Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease. Antioxidants 12:4, pages 894.
Crossref
Thekkayil Sangeetha & Senthilkumar Lakshmipathi. (2023) Intramolecular interactions (O-H∙∙∙O, C-H∙∙∙N, N-H∙∙∙π) in isomers of neutral, cation, and anion dopamine molecules: A DFT study on the influence of solvents (water and ethanol). Journal of Molecular Modeling 29:3.
Crossref
Aparna Ann Mathew, Sudeshna Mohapatra & Rajitha Panonnummal. (2022) Formulation and evaluation of magnesium sulphate nanoparticles for improved CNS penetrability. Naunyn-Schmiedeberg's Archives of Pharmacology 396:3, pages 567-576.
Crossref
Harsh Shah, Fereshteh Dehghani, Marjan Ramezan, Ritchel B. Gannaban, Zobayda Farzana Haque, Fatemeh Rahimi, Soheil Abbasi & Andrew C. Shin. (2023) Revisiting the Role of Vitamins and Minerals in Alzheimer’s Disease. Antioxidants 12:2, pages 415.
Crossref
Jeanette A. M. Maier, Laura Locatelli, Giorgia Fedele, Alessandra Cazzaniga & André Mazur. (2022) Magnesium and the Brain: A Focus on Neuroinflammation and Neurodegeneration. International Journal of Molecular Sciences 24:1, pages 223.
Crossref
Zhichao Zhong, Xingrui He, Jiamin Ge, Junlong Zhu, Chuansheng Yao, Hong Cai, Xiang-Yang Ye, Tian Xie & Renren Bai. (2022) Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification. European Journal of Medicinal Chemistry 237, pages 114378.
Crossref
Ke Du, Xi Zheng, Zi-Tai Ma, Jun-Ya Lv, Wen-Juan Jiang & Ming-Yan Liu. (2022) Association of Circulating Magnesium Levels in Patients With Alzheimer's Disease From 1991 to 2021: A Systematic Review and Meta-Analysis. Frontiers in Aging Neuroscience 13.
Crossref
Olakunle J. Onaolapo, Ademola O. Odeniyi & Adejoke Y. Onaolapo. (2021) Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?. CNS & Neurological Disorders - Drug Targets 20:4, pages 343-365.
Crossref
Aparna Ann Mathew & Rajitha Panonnummal. (2021) ‘Magnesium’-the master cation-as a drug—possibilities and evidences. BioMetals 34:5, pages 955-986.
Crossref
Runnan Xu, Liping Wang, Liyuan Sun & Jianghui Dong. (2021) Neuroprotective effect of magnesium supplementation on cerebral ischemic diseases. Life Sciences 272, pages 119257.
Crossref
Frank C. Church. (2021) Treatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease. Biomolecules 11:4, pages 612.
Crossref
Yutaka Shindo, Ryu Yamanaka, Kohji Hotta & Kotaro Oka. (2020) Inhibition of Mg2+ Extrusion Attenuates Glutamate Excitotoxicity in Cultured Rat Hippocampal Neurons. Nutrients 12:9, pages 2768.
Crossref
Mary-Frances E. Hall & Frank C. Church. (2020) Integrative Medicine and Health Therapy for Parkinson Disease. Topics in Geriatric Rehabilitation 36:3, pages 176-186.
Crossref